Organization: Health Canada
Year: 2021
Month: August
Request Number: A-2020-001893
Request Summary: Adverse Reaction Reports (AERs) for Mesalazine. Report numbers: E2B_03359485, 924994, 926580, E2B_03337925, E2B_03342971, E2B_03403768. (ADRs) for C1 Esterase Inhibitor (Human). Report numbers: E2B_03394037, E2B_03350562. (ADR) for GAMMAGARD LIQUID. Report number: 921422. (ADRs) for Immunoglobulin (human). Report numbers: E2B_03394199, E2B_03353109, E2B_03393837.
Disposition: Disclosed in part
Number of pages: 84